Encephale
-
According to a recent change in the French legislation (2010) regarding the regulation of the use of the title of "psychotherapist", psychiatrists are now allowed to use this title at the end of their training, without any additional training. However, various publications from 2000 have shown that there is no specific training in psychotherapy at a professional level during the training of psychiatrists. ⋯ Our results show a clear discrepancy between the importance of training in psychotherapy for psychiatrists, the interest of psychiatry students for these therapies, and the very high rate of dissatisfaction for the training received, as well as the rate of students supervised during their training period at the hospital. These results differ from what is observed in other countries, where satisfaction rates are much higher among students, and various psychotherapy training methods are proposed in a much more homogeneous manner. More research is required to understand the reasons for these difficulties with the psychotherapy training of psychiatrists in France, and to propose new models of training to improve this situation.
-
Poor adherence is a major concern for the effectiveness of antipsychotic treatment in patients with schizophrenia. In particular, compliance problems constitute a poor prognostic factor for this disorder due to increasing risk of relapse and hospitalization. As maintaining antipsychotic therapy is a key element to prevent relapse, the use of depot preparations is therefore considered as a useful therapeutic option since it prevents covert non-adherence. When compared with neuroleptics, novel antipsychotic agents are also better tolerated by patients. In this study, the rationale for the use of long-acting injectable risperidone combining the benefits of novel antipsychotic agent and depot preparation is investigated in patients with psychosis. A secondary objective of the study is to assess the level of therapeutic adherence and to confirm the role of its key determinants. ⋯ In this French survey, the two main reasons for psychiatrists to start long-acting injectable risperidone were related to non-compliance with oral antipsychotic treatment and with the desire to improve therapeutic efficacy. In accordance with results of previous studies, insight and therapeutic alliance were found to be associated with poor compliance. The main goal in the treatment of psychotic disorders is to obtain a functional remission and to reduce the incidence of relapse. Considering its improved efficiency and reduced dependence on patient compliance, the use of long-acting injectable risperidone is recommended as a useful therapeutic strategy.
-
The aim of this review of the literature is to summarise the definitions of metacognition, the measurement tools, the results of studies investigating metacognition in persons with schizophrenia and the therapeutic perspectives. ⋯ These data suggest that remediation programs specifically targeting metacognitive deficits have to be further developed.
-
Chronic depression is a frequent disorder and is usually treated using traditional approaches. These approaches rarely take into account the psychopathological specificities of the chronic evolution of the disorder. ⋯ We underline the relevance of the approach by citing several empirical studies which have established the efficacy of the model, in specific clinical conditions that are the combined treatment with anti-depressant medication, a sufficient number of sessions and in the case of early trauma as etiological factor of the chronic depression. We discuss the application of CBASP to other clinical diagnoses, such as borderline and avoidant personality disorder as well as disorders related to substance abuse and thus argue in favor of CBASP as a central model in the treatment of various mental illnesses.
-
To describe health-related quality of life (HRQoL), pain, clinical outcomes and treatment patterns in French patients with depression treated by general practitioners and psychiatrists. ⋯ More than half of the French patients enrolled in the study experienced pain associated with depression. During follow-up, patients improved all of their outcome measurements (physical and mental SF-36 scores, depression and anxiety HADS scores, pain VAS, EQ-5D Health State Index and VAS) and most patients remained on the same antidepressant at the same dose.